Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 338

Posts Tagged ‘annual’

An “Annual Monitoring Cycle” with preventive and corrective measures

Posted by fidest press agency su domenica, 27 settembre 2020

to protect the European Union’s legal order, the fundamental rights of its citizens, and its international credibility from the deterioration of Article 2 TEU values, MEPs propose an objective and evidence-based tool that would apply equally, objectively and fairly to all member states, while respecting the principles of subsidiarity and proportionality. This new “Annual Monitoring Cycle” must include preventive and corrective measures, ranging from country-specific recommendations to budgetary conditionality. To this end, the three EU institutions should establish a permanent “Interinstitutional Working Group on Union Values”, which will hear from a panel of independent experts in cooperation with the EU Agency for Fundamental RightsThe Committee’s proposal aspires to integrate and complement existing mechanisms, such as those provided in Article 7 TEU. MEPs regret the Council’s inability to make meaningful progress in ongoing Article 7 procedures and note that this failure “is in fact enabling continued divergence”. They welcome the Commission’s work on the Annual Rule of Law Report, among other instruments, whilst pointing out that the areas of democracy and fundamental rights should not have been omitted from it.

Posted in Estero/world news, Politica/Politics | Contrassegnato da tag: , , , | Leave a Comment »

61st ASH Annual Meeting and Exposition

Posted by fidest press agency su giovedì, 12 dicembre 2019

Bio, Inc. (Nasdaq: BLUE) announced new data from its ongoing Phase 1/2 HGB-206 study of investigational LentiGlobin™ gene therapy for sickle cell disease (SCD), including additional patients treated in the study and updated data for those previously reported. These data, as well as results from exploratory assays designed to assess the relationship between drug product characteristics and red blood cell physiology, were presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Florida. SCD is a serious, progressive and debilitating genetic disease caused by a mutation in the β-globin gene that leads to the production of abnormal sickle hemoglobin (HbS), causing red blood cells (RBCs) to become sickled and fragile, resulting in chronic hemolytic anemia, vasculopathy and painful vaso-occlusive crises (VOCs). For adults and children living with SCD, this means unpredictable episodes of excruciating pain due to vaso-occlusion as well as other acute complications—such as acute chest syndrome (ACS), stroke and infections, which can contribute to early mortality in these patients. LentiGlobin for SCD was designed to add functional copies of a modified form of the β-globin gene (βA-T87Q-globin gene) into a patient’s own hematopoietic (blood) stem cells (HSCs). Once patients have the βA-T87Q-globin gene, their RBCs can produce anti-sickling hemoglobin that decreases the proportion of sickled hemoglobin, with the goal of reducing sickled RBCs, hemolysis and other complications.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

26th Annual Venture Capital & Private Equity Conference

Posted by fidest press agency su martedì, 10 dicembre 2019

The Venture Capital & Private Equity Club, the largest student club at Harvard Business School, will hold its 26th annual Venture Capital & Private Equity Conference on Saturday, February 8, 2020, on the Harvard Business School campus in Boston. One of Harvard Business School’s most anticipated student-run conferences, the one-day event will host more than 1,000 professionals and students to discuss the most pressing issues facing today’s alternative investing industry. Several new panel topics will be introduced this year, including panels on Frontier Technologies, First Time Funds, Mobility, and Investing in China. Also on the agenda are many of last year’s popular topics, including panels on the State of PE, State of VC, Technology, Healthcare, Consumer, and more. More than 300 senior professionals from leading private equity and venture capital firms from around the country will participate in the conference.
“The HBS Venture Capital & Private Equity Conference continues to be one of the most reputable and prominent events at the business school level,” said Tony James, Executive Vice Chairman of The Blackstone Group. “I am excited to be speaking at this noteworthy event which brings together some of the most talented and respected alternative investment professionals. I look forward to exchanging views on the private equity and venture capital industries.”“We are very pleased to have once again the distinct opportunity and pleasure of hosting the VCPE Conference,” said John Dionne, Senior Lecturer of Business Administration at Harvard Business School. “The conference has continued to evolve and attract very highly regarded participants and attendees, which is a credit to the past and present members of HBS’ highly regarded Venture Capital and Private Equity Club. We are thrilled to once again welcome to campus some of the brightest minds in the alternative investing space and facilitate robust debate.” “Having been fortunate enough to be a graduate of Harvard Business School, I have seen firsthand how this conference continues to reinvent itself and offer unique keynotes and panels that are relevant to both the current and future states of the global alternative investment space,” said Jim Breyer, Founder and Chief Executive Officer of Breyer Capital. “The VCPE team spends an extraordinary amount of time and effort to put together a thoughtful and quality agenda that provides attendees with key takeaways that they can apply to their respective careers and personal ambitions. In addition to providing my thoughts and insights as an early-stage investor, I am eager to hear the views of other participants, scholars, and students, and look forward to another successful event.”

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

31st Annual Healthcare Conference

Posted by fidest press agency su venerdì, 29 novembre 2019

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that Richard Rubino, Chief Financial Officer, will present in a fireside discussion at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 8:00 a.m. Eastern Time in New York, NY. Mr. Rubino will provide an Aerie overview and provide a business update. The fireside discussion will be webcast live and may be accessed by visiting Aerie’s website at A replay of the webcast will be available for 10 business days.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

31st Annual Piper Jaffray Healthcare Conference

Posted by fidest press agency su domenica, 24 novembre 2019

Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at a new time of 9:30 AM Eastern Time. The presentation will be webcast live and available on the events page of the Aruna Bio website ( and via the link below. A replay of the webcast will be available following the conference at
Drs. Sirgo and Stice will discuss the utilization of neural exosomes as both a therapeutic and a delivery vehicle to treat neurodegenerative diseases and stroke. The presentation will include data on Aruna Bio’s proprietary neural exosome platform, which has demonstrated therapeutic benefit in multiple animal models of stroke and is also being developed for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Dr. Sirgo will also discuss the company’s going forward strategy and key milestones for 2020.
Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. Aruna Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The American Society of Nephrology Kidney Week 2019 Annual Meeting

Posted by fidest press agency su venerdì, 8 novembre 2019

Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced it will present one oral and two poster presentations at the American Society of Nephrology (ASN) Kidney Week 2019 Annual Meeting, taking place November 5-10, 2019, in Washington, D.C.The oral presentation will address the ways in which Goldfinch Bio’s platform generates induced pluripotent stem cell (iPSC)-derived human podocytes and kidney organoids to enable target validation and preclinical assessment of prospective therapies for kidney disease. The poster presentations will include data on how GFB-887, a sub-type selective, small molecule transient receptor potential canonical 5 (TRPC5) ion channel inhibitor, was effective in reducing proteinuria in animal models of focal segmental glomerulosclerosis (FSGS) and other kidney diseases, as well as data on how Goldfinch Bio’s proprietary Kidney Genome AtlasTM can be leveraged to unravel molecular mechanisms of kidney diseases.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

28th Annual Healthcare Conference

Posted by fidest press agency su giovedì, 7 novembre 2019

Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019 at 10:20 a.m. Mountain Time. The presentation will be webcast live and available for replay from Seattle Genetics’ website at in the Investors section.
Seattle Genetics, Inc. is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) utilizes the Company’s industry-leading antibody-drug conjugate (ADC) technology and is currently approved for the treatment of multiple CD30-expressing lymphomas. Beyond ADCETRIS, the Company has established a pipeline of novel targeted therapies at various stages of clinical testing, including three in ongoing pivotal trials for solid tumors. Enfortumab vedotin for metastatic urothelial cancer, that is currently being reviewed for approval by the FDA, and tisotumab vedotin for metastatic cervical cancer utilize our proprietary ADC technology. Tucatinib, a small molecule tyrosine kinase inhibitor, is in clinical trials for HER2-positive metastatic breast cancer and metastatic colorectal cancer. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors. The Company is headquartered in Bothell, Washington, and has a European office in Switzerland. For more information on our robust pipeline, visit and follow @SeattleGenetics on Twitter.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Fourth Annual 2019 Hawaii Payments University

Posted by fidest press agency su giovedì, 7 novembre 2019

ACH Alert, an award-winning provider of electronic payments fraud prevention technology for financial institutions of all sizes, announced it is attending the 2019 Hawaii Payments University & Fraud Day for the second year, taking place November 5-7 in Honolulu. The conference is hosted by PacPay, Federal Reserve Bank and PAR/WACHA.Payments University is an intense, collegiate-style learning environment structured to provide holistic, concentrated payments education. The multi-track agenda provides targeted education through fundamental and advanced courses for both new and seasoned industry veterans, designed to allow participants to choose which sessions to attend based on desired topics. During the conference, Deborah Peace, CEO of ACH Alert, will participate in Fraud Day by leading the session, Combatting Fraud: The Role of Voice Biometrics in Your Layered Security Program. Peace will also help moderate the interactive session, Advanced Exception Handling and Case Studies, to focus on challenges facing the employees and call centers managing ACH processing. Lastly, Peace will take part in the Payments Risk Management session to explore different kinds of risk each payment channel presents and offer solutions for managing those risks.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

28th Annual Healthcare Conference

Posted by fidest press agency su venerdì, 1 novembre 2019

ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.m. (Mountain Standard Time) at The Phoenician in Scottsdale, AZ. More information about this event, including a live webcast, may be accessed by visiting The webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 90 days following the conference.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 120 countries.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

5th Annual Israel Conference

Posted by fidest press agency su sabato, 19 ottobre 2019

Perion Network Ltd. (NASDAQ: PERI), a global technology company that delivers Synchronized Digital Branding solutions across the three main pillars of digital advertising – Ad Search, Social media and Display / Video, announced today that the Company will participate in the H.C. Wainwright 5th Annual Israel Conference on Sunday, November 10, 2019 at the Hilton Hotel in Tel Aviv, Israel.Doron Gerstel, Perion’s Chief Executive Officer, and Maoz Sigron, Perion’s Chief Financial Officer, are scheduled to meet with investors on Sunday, November 10th, with one-on-one meetings to be held throughout the day.
Perion is a global technology company that provides agencies, brands and publishers with innovative solutions that cover the three pillars of digital advertising. From its data-driven Synchronized Digital Branding platform and high-impact ad formats in the display domain; to its powerful social media platform; to its branded search network, Perion is well-positioned to capitalize on any changes in marketers’ allocation of digital advertising spend. More information about Perion can be found at

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

3rd Annual Genetic Medicines Conference

Posted by fidest press agency su lunedì, 7 ottobre 2019

The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Chardan 3rd Annual Genetic Medicines Conference on Tuesday, October 8, 2019, in New York. The Company is scheduled to participate in a “fireside chat” discussion at 8:00 a.m. Eastern Daylight Time.A live audio webcast will be available on The Medicines Company Investor Relations website and a replay of the presentation will be available within 48 hours of the event.
The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today – cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C. The Company is headquartered in Parsippany, New Jersey.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

8th Annual Research Conference

Posted by fidest press agency su martedì, 1 ottobre 2019

OptionMetrics, an options database and analytics provider for international institutional investors and academic researchers, is announcing Dean Curnutt, Founder and CEO of Macro Risk Advisors, will keynote its 8th Annual Research Conference (ORC2019), Monday, October 28, at Fordham University, New York City. To provide perspective on the current market, Curnutt will provide a retrospective look at some of the largest blow-ups in the derivatives market, what happened, and why, in his talk, “Steroids, Credit Growth and the Derivatives Blow Up Hall of Fame.”Under Curnutt’s leadership, Macro Risk Advisors has become the highest ranked boutique in the Tabb Group Survey of Option Research providers and offers in-depth global market risk analysis and transaction execution services. Curnutt formerly was managing director and head of equity sales-trading at Banc of America Securities. A recognized expert on risk and cross-asset volatility, he frequently appears on Bloomberg TV to share his views on markets and has delivered keynote presentations at the CBOE Risk Management Conference. Curnutt was named a “Rising Star of Hedge Funds” by Institutional Investor. He is an adjunct professor of finance and a member of the Board of Governors at St. John’s University.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

WarnerMedia: first-ever annual report

Posted by fidest press agency su martedì, 1 ottobre 2019

WarnerMedia today released its first-ever annual report looking at diversity, inclusion and belonging across both its corporate operations and the films, television series and digital content created by its various production businesses. In September 2018, WarnerMedia announced a Production Diversity Policy which included the commitment to report on its diversity and inclusion efforts annually.The report, covering 2018, highlights diversity, inclusion and belonging across three areas at WarnerMedia: Workforce (including workforce composition, Employee Resource Groups), Content (including scripted TV, films, news, animation) and Community (including industry and local outreach partnerships and programs).Among the key findings related to workforce and production staffing:
WarnerMedia’s global workforce is 54% male and 46% female, and its U.S. workforce is 53% male and 47% female. Globally, half of all new hires and promotions to Vice President and above are women 42% of Non-Managers are People of Color, but representation decreases at more senior levels. However, the percentage of People of Color who were hired or promoted in 2018 exceeds their total percentage across all levels. This will lead to increased representation going forward. Across WarnerMedia’s non-film scripted programming, females represent 34% of onscreen roles and 23% of behind-the-camera positions.
Across WarnerMedia’s non-film scripted programming, People of Color represent 24% of onscreen roles and 23% of behind-the-camera positions.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

21st Annual Global Investment Conference

Posted by fidest press agency su domenica, 8 settembre 2019

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to the A3 adenosine receptor (A3AR), addressing cancer, liver and inflammatory diseases, announced today the Company’s CEO Dr. Pnina Fishman will present at the H. C. Wainwright 21st Annual Global Investment Conference to be held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City.Dr. Fishman will present on Tuesday, September 10th at 3:00 p.m. in the Kennedy I room, 4th floor. Company executives will also conduct one-on-one meetings with institutional investors.
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company’s lead drug candidate, Piclidenoson, is currently in Phase III trials for rheumatoid arthritis and psoriasis. Can-Fite’s liver cancer drug, Namodenoson, recently completed a Phase II trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and is in a Phase II trial for the treatment of non-alcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. CF602, the Company’s third drug candidate, has shown efficacy in the treatment of erectile dysfunction in preclinical studies and the Company is investigating additional compounds, targeting A3AR, for the treatment of sexual dysfunction. These drugs have an excellent safety profile with experience in over 1,000 patients in clinical studies to date.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

22nd Annual ‘Back to School’ Program

Posted by fidest press agency su giovedì, 5 settembre 2019

To help students in need around the world return to school with confidence, Henry Schein, Inc. (Nasdaq: HSIC) recently held its 22nd annual “Back to School” program. This year, the Company provided nearly 5,000 children with backpacks and school supplies at 32 Henry Schein locations in the U.S., Canada, Ireland, Spain, and Wales. Since the program’s inception in 1998, the Company has helped more than 50,000 children head back to the classroom with confidence.
Children who participate in “Back to School” also take home books and hygiene products donated by Henry Schein, and at many Company locations, first-day-of-school outfits purchased by Team Schein Members. The “Back to School” program is a flagship initiative of Henry Schein Cares, the Company’s global corporate social responsibility program. “Team Schein looks forward to the ‘Back to School’ program every year because it gives us an opportunity to give back to our community and help these amazing kids start another successful school year,” said Gerry Benjamin, Executive Vice President and Chief Administrative Officer of Henry Schein. “It’s incredible to think that the ‘Back to School’ program is more than 20 years old, but I believe I speak for all of Team Schein when I say our commitment to this program and these families grows stronger every year.”
The Company recently hosted a “Back to School” event for approximately 600 children and their families at its worldwide headquarters in Melville, N.Y. In addition to new clothes and school supplies, the children enjoyed dinner, games, music, crafts, and other fun activities. The children also received free books at the event thanks to the generous support of KPMG LLP – the U.S. audit, tax, and advisory firm – through its Family for Literacy program and partnership with nonprofit social enterprise First Book. A video from the event can be viewed here.The company partnered with 10 local social service organizations to pre-identify the participating children and their families: Bethany House; Espoir Youth Program, Inc.; Family and Children’s Association; Family Service League; Hispanic Counseling Center; Madonna Heights; Nassau County Department of Social Services; The Raymar Children’s Fund; WellLife Network; and YES Community Counseling Center.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

5th Annual Immuno-oncology BD&L and Investment Forum

Posted by fidest press agency su domenica, 26 Maggio 2019

Chicago, Illinois Friday, May 31, 2019 10:30 AM Waldorf Astoria Chicago Hotel, immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced that the company will present at the 5th Annual Immuno-oncology BD&L and Investment Forum. Sia Anagnostou, Immunomic’s Senior Director of Corporate Development, will present a company overview and will discuss ITI’s recently expanded, investigational UNiversal Intracellular Targeted Expression (UNITE) platform and its application in immuno-oncology, specifically glioblastoma multiforme (GBM). ITI’s technology platform has the potential to utilize the body’s natural biochemistry to develop a broad immune response and is currently being employed in a Phase II clinical trial as a cancer immunotherapy.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

17th Annual Solar Cup

Posted by fidest press agency su domenica, 19 Maggio 2019

As students from 40 high schools gear up for the 17th annual Solar Cup™, preliminary scores heading into this weekend’s contest show Costa Mesa High leading the pack, with La Puente’s Nogales High and Oxford Academy in Cypress trailing closely behind.Hosted by the Metropolitan Water District of Southern California, the nation’s largest solar-powered boat competition officially launches Friday (May 17) with boat inspections and qualifying for Saturday’s 90-minute endurance heats and Sunday’s 200-meter sprints at Lake Skinner in the Temecula Valley.While the head-to-head competition officially kicks off Friday, the contest started long before the students even set their boats on the lake. Over the past seven months, teams have been earning points for writing technical reports detailing how they built their boats’ electrical systems and drivetrains, producing a public service announcement promoting water conservation, and passing a technical inspection of their boats. These projects and other requirements represent roughly a third of the total possible points for the Solar Cup competition.In addition to earning high marks for both their technical reports, Costa Mesa High students garnered the most points for their public service announcement. The team’s creative video, developed in partnership with their co-sponsoring agency Mesa Water District, focused on the district’s water conservation efforts and shared effective tips for local residents to reduce their water use.Both Nogales and Oxford high schools also showed strong performances in all preliminary categories, earning second and third place for their PSAs, respectively. Using an effective and energetic narrator, Nogales High shared the benefits of planting California native landscapes, using their own high school campus as a backdrop. Oxford Academy presented information about Orange County’s water sources and California’s recent historic drought conditions to push the public to conserve more water. Metropolitan posted the top five student-produced conservation PSAs on the district’s Twitter account throughout this week.Prior to making qualifying runs Friday, the boats will be inspected and tested by Metropolitan and a technical advisory team from Occidental College to ensure they meet the program’s requirements and are safe and seaworthy. Saturday features two 90-minute endurance heats around a 1.6-kilometer course. The contest continues Sunday with the sprint races, closing with an awards ceremony in the afternoon. The single-seat boats, 16-feet-long, are built from kits of marine-grade plywood provided by Metropolitan. Teams equip them with steering, solar panels, batteries and motors producing up to 320 watts. The maximum weight, including the skipper, is 450 pounds.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Altai Capital Responds to Amber Road’s Postponement of Annual Meeting

Posted by fidest press agency su sabato, 20 aprile 2019

Altai Capital Management, L.P. (“Altai Capital”), one of the largest shareholders of Amber Road, Inc. (NYSE: AMBR) (“Amber Road” or, the “Company”), today issued the following statement regarding the Company’s sudden announcement that it will postpone the 2019 Annual Meeting of Stockholders (the “Annual Meeting”), which was originally scheduled for May 7, 2019, by more than a month to June 18, 2019.“The unexplained decision of Amber Road’s Board to postpone the Annual Meeting appears to us to be a clear attempt to further entrench the Board and avoid accountability. We believe investors deserve the opportunity to voice, without delay, their frustration at the strategic missteps of the Company’s leadership. By delaying the shareholders’ right to elect directors at the appropriate meeting time, we believe the Company is perpetuating the pattern of self-serving actions and value destruction that have characterized Amber Road to date. We see no valid purpose for postponing the Annual Meeting and question the Board’s decision to do so only days before the scheduled date and after proxies have already been delivered to shareholders. In the absence of any explanation, we can only conclude that the Board is trying to buy more time to gather support they do not believe they have. As we have stated all along, Amber Road’s Board is in critical need of improvement—fresh, independent minds are essential to hold management accountable, to properly explore strategic alternatives and to provide shareholders with the transparency they deserve. This Board’s delay tactics only reinforce our concerns, serving as an acute reminder that the Company’s current Board, in our view, prioritizes its desire to stay in office over respecting the rights of its shareholders. To the extent that the current Board is deliberating on material decisions, we strongly believe that such deliberations should be conducted by a new, duly elected Board best-positioned to represent the best interests of all shareholders.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

18th Annual Needham Healthcare Conference

Posted by fidest press agency su martedì, 9 aprile 2019

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer, will present at the 18th Annual Needham Healthcare Conference Eastern Time in New York. A live webcast of the presentation will be available on the company’s website at To access, please log onto the Akebia website at least 15 minutes prior to the webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Akebia’s website following the conference.
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at, which does not form a part of this release.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

13th Annual User Conference

Posted by fidest press agency su mercoledì, 13 marzo 2019

Many of the world’s top IP practitioners will come together for four days in March for a major industry event hosted by Anaqua, the leading provider of innovation and intellectual property management solutions. Under the theme of ‘Transform IP into Business Success,’ Anaqua’s 13th annual User Conference will be held at the Loews Royal Pacific Resort in Orlando, Florida from March 25th-28th. The four-day event brings together IP professionals across the globe to collaborate and share key insights on how to further innovate and enhance solutions that will best serve the intellectual property management industry. Anaqua’s client community will join industry discussions, participate in training sessions, engage in networking events, and hear from business leaders and industry influencers as they share key trends, insights, and best practices. “We have the most innovative customers in the world who are shaping the IP industry,” said Bob Romeo, CEO of Anaqua. “Anaqua’s annual User Conference gives these leaders the opportunity to come together to share insights and best practices that will move the needle and enhance the ANAQUA platform. Together, we are innovating and enhancing the industry’s IP management solutions and services that make this year’s theme possible for the market, ‘Transform IP into Business Success.’”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »